Long-short factor portfolios are constructed on the assumption that the two legs are complementary drivers of factor premiums. In our research paper,1 we critically assess this notion by breaking down the Fama–French style portfolios – low risk, momentum, value, profitability and investments (the latter two are often referred to as quality) – into their long and short legs. Although we find that factor premiums originate in both, it is evident that most of the added value tends to come from the long positions.
The Sharpe ratios have been highest for the long legs of factors and lowest for the short legs’
Moreover, our research shows that the long legs of factors offer more diversification than the short ones, while the performance of the shorts is generally subsumed by the longs. This outcome is particularly driven by a high common risk in short positions. This can be ascribed to the relatively high correlations between the shorts legs of various factors as well as between the shorts and longs of individual factors. As a result, we observed that the Sharpe ratios have been highest for the long legs of factors and lowest for the short legs.
These results are confirmed in a series of robustness checks. They hold across large and small caps, as in both cases, the long positions contribute the most to factor premiums. They are robust over time and across international equity markets, and cannot be attributed to differences in tail risk. Thus, the long legs are crucial for understanding factor premiums, while no essential information is lost by dropping the short legs. All in all, the shorts offer essentially the same exposure as the longs, but with lower rewards and more risks.
Therefore, factor premiums can be more efficiently harvested by dropping short positions and focusing only on the long ones. Our findings do not even account for the substantially higher implementation costs borne by short positions compared to long ones. Additionally, short selling faces the impact of liquidity and capacity limits, as well as other risks, like the potential of unlimited losses, ‘short squeeze’ scenarios, counterparty risk and reputational risk.
Finally, our research also challenges recent claims that the low risk and value factors are subsumed by the new Fama-French factors, as this hypothesis holds for the short positions of these factors but breaks down for the long ones. To this end, we establish that the long legs of both the low risk and value factors offer distinct premiums that cannot be explained by the longs of other factors. Read the full research paper
1 Blitz, D. C., Baltussen, G. and Van Vliet, P., 2020, “When equity factors drop their shorts”, Financial Analysts Journal.
The information contained on these pages is for marketing purposes and solely intended for Qualified Investors in accordance with the Swiss Collective Investment Schemes Act of 23 June 2006 (“CISA”) domiciled in Switzerland, Professional Clients in accordance with Annex II of the Markets in Financial Instruments Directive II (“MiFID II”) domiciled in the European Union und European Economic Area with a license to distribute / promote financial instruments in such capacity or herewith requesting respective information on products and services in their capacity as Professional Clients.
The Funds are domiciled in Luxembourg and The Netherlands. ACOLIN Fund Services AG, postal address: Affolternstrasse 56, 8050 Zürich, acts as the Swiss representative of the Fund(s). UBS Switzerland AG, Bahnhofstrasse 45, 8001 Zurich, postal address: Europastrasse 2, P.O. Box, CH-8152 Opfikon, acts as the Swiss paying agent. The prospectus, the Key Investor Information Documents (KIIDs), the articles of association, the annual and semi-annual reports of the Fund(s) may be obtained, on simple request and free of charge, at the office of the Swiss representative ACOLIN Fund Services AG. The prospectuses are also available via the website www.robeco.ch. Some funds about which information is shown on these pages may fall outside the scope of the Swiss Collective Investment Schemes Act of 26 June 2006 (“CISA”) and therefore do not (need to) have a license from or registration with the Swiss Financial Market Supervisory Authority (FINMA).
Some funds about which information is shown on this website may not be available in your domicile country. Please check the registration status in your respective domicile country. To view the RobecoSwitzerland Ltd. products that are registered/available in your country, please go to the respective Fund Selector, which can be found on this website and select your country of domicile.
Neither information nor any opinion expressed on this website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco Switzerland Ltd. product should only be made after reading the related legal documents such as management regulations, prospectuses, annual and semi-annual reports.